Voltage-gated potassium channels (Kv1/Shaker/KCNA family)

Class

Small molecule voltage-gated potassium channel blocker

Pathway

Blocks Kv1 channels, prolonging action potentials in demyelinated axons and restoring nerve conduction (symptomatic walking-impairment treatment, not immunomodulatory)

Voltage-gated potassium channels of the Kv1 (Shaker/KCNA) family are membrane proteins that open after a nerve cell fires, allowing potassium ions to exit and return the cell membrane to its resting state so it can fire again. In healthy myelinated nerve fibers, these channels are largely hidden beneath the insulating myelin sheath. When myelin is damaged, as occurs in demyelinating disease, Kv1 channels become exposed along the axon and their potassium efflux can dissipate the electrical signal before it completes its journey, leading to conduction failure and impaired nerve signaling. Blocking these exposed channels delays potassium efflux, prolongs the action potential, and helps the nerve impulse propagate across the damaged segment. This approach does not repair myelin or alter the underlying disease process; it is a symptomatic strategy aimed at improving nerve conduction and, in conditions such as multiple sclerosis, walking function. The same basic principle could be relevant wherever demyelination compromises axonal signaling, though clinical use has centered on mobility impairment. Because Kv1 channels are broadly expressed in the nervous system, the strategy requires balancing conduction benefits against effects on neurons where these channels are not exposed.